Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Editors Pick
    • Solution to antibiotic...

    Solution to antibiotic resistance - Researchers develop novel antibiotics

    Written by Medha Baranwal Baranwal Published On 2019-07-17T20:20:53+05:30  |  Updated On 11 Aug 2021 4:52 PM IST

    France: In this world of increasing frequency of antibiotic resistance, that renders antibiotics ineffective, there arises a need for antibiotic alternatives that do not trigger resistance. In a bid to search for the same, a team of French researchers have developed a novel class of antibiotics that were effective against gram-positive and negative multi-resistant bacteria. Most importantly, the new antibiotics did not trigger resistance or cause toxicity while they were experimented to cause toxicity in mice. The antibiotic is based on a natural bacterial toxin.


    The study is published in the journal PLOS Biology.

    Antibiotics are medical wonders but their overuse has led to the development of antibiotic resistance and emergence of superbugs. According to WHO, antibiotic resistance is the biggest threats to human health globally and is expedited by antibiotic misuse in both humans and animals.


    Also Read: WHO releases 2019 updated list of essential medicines, adds new antibiotics to the list

    The team led by Brice Felden, Director of the Bacterial Regulatory RNAs and Medicine laboratory in Rennes, synthesized and designed the compounds called peptidomimetics, by imitating a section of a toxin produced by S aureus to kill other bacteria (PepA). In a test against a broad spectrum of gram-negative and gram-positive pathogens, Pep16 and Pep19 were found to be effective against methicillin-resistant S aureus (MRSA) and Pseudomonas aeruginosa in mouse models. The number of deaths from MRSA is increasing each year and by the year 2050, it is estimated that at least 10 million people will die annually as a result of antimicrobial resistance.


    Testing of the compounds on human erythrocytes and kidney cells, zebrafish embryos, and mice showed no toxicity. In addition, after 2 weeks of serial passage performed against multidrug-resistant clinical isolates in vitro, and 4 or 6 days exposure in mice infected with MRSA, the compounds showed no development of resistance.


    Also Read: Bacteriophages-Key to counter antibiotic resistance found in kitchen Sponge

    Analysis of the mechanism of action indicates the compounds are able to permeate the cell membranes of gram-positive and gram-negative bacteria, leading to bacterial death.


    "We have identified potential therapeutic agents that can provide alternative treatments against antimicrobial resistance. Because the compounds are potential leads for therapeutic development, the next step is to start phase I clinical trials," concluded the authors.


    To read the complete study follow the link: https://doi.org/10.1371/journal.pbio.3000337

    Brice FeldenGram negativeGram positiveindian medical newsMedical newsmisuseMRSAmulti-resistant bacteriamultidrug-resistantNew AntibioticsNoveloverusePep16Pep19PepApeptidomimeticsPLOS BiologyPseudomonas aeruginosarecent medical newstoxicity

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok